Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).

MLA

Ruwald, Anne-Christine, et al. “Mortality Reduction in Relation to Implantable Cardioverter Defibrillator Programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).” Circulation. Arrhythmia and Electrophysiology, vol. 7, no. 5, Oct. 2014, pp. 785–92. EBSCOhost, https://doi.org/10.1161/CIRCEP.114.001623.

APA

Ruwald, A.-C., Schuger, C., Moss, A. J., Kutyifa, V., Olshansky, B., Greenberg, H., Cannom, D. S., Estes, N. A. M., Ruwald, M. H., Huang, D. T., Klein, H., McNitt, S., Beck, C. A., Goldstein, R., Brown, M. W., Kautzner, J., Shoda, M., Wilber, D., Zareba, W., & Daubert, J. P. (2014). Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT). Circulation. Arrhythmia and Electrophysiology, 7(5), 785–792. https://doi.org/10.1161/CIRCEP.114.001623

Chicago

Ruwald, Anne-Christine, Claudio Schuger, Arthur J Moss, Valentina Kutyifa, Brian Olshansky, Henry Greenberg, David S Cannom, et al. 2014. “Mortality Reduction in Relation to Implantable Cardioverter Defibrillator Programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).” Circulation. Arrhythmia and Electrophysiology 7 (5): 785–92. doi:10.1161/CIRCEP.114.001623.